Insider Transactions in Q4 2021 at Janux Therapeutics, Inc. (JANX)

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
Dec 29 2021	Peter A. Thompson Director	SELL Open market or private sale	Indirect	40,400 -1.59%	$808,000 $20.3 P/Share
Dec 29 2021	Orbimed Advisors LLC Director	SELL Open market or private sale	Indirect	40,400 -1.59%	$808,000 $20.3 P/Share
Dec 21 2021	Peter A. Thompson Director	SELL Open market or private sale	Indirect	119,400 -4.51%	$2,268,600 $19.0 P/Share
Dec 21 2021	Orbimed Advisors LLC Director	SELL Open market or private sale	Indirect	119,400 -4.51%	$2,268,600 $19.0 P/Share
Dec 16 2021	Peter A. Thompson Director	SELL Open market or private sale	Indirect	393,300 -12.93%	$7,472,700 $19.07 P/Share
Dec 16 2021	Orbimed Advisors LLC Director	SELL Open market or private sale	Indirect	393,300 -12.93%	$7,472,700 $19.07 P/Share

Receive a notification when an Institution or Guru buys or sells JANX shares.

Notify only if

Value

Get notified when an Janux Therapeutics, Inc. insider buys or sells JANX shares.

Notify only if

Operation

Value

Type

Receive news related to Janux Therapeutics, Inc.